Una escasez de un fármaco hace que muchos con un cáncer de próstata avanzado no reciban tratamiento
MARTES, 21 de marzo de 2023 (HealthDay News) — Una escasez actual de un medicamento para los hombres con un cáncer de próstata avanzado está haciendo que algunos pacientes no reciban un tratamiento con el potencial de alargar sus vidas durante meses….
Learn MoreMedication Shortage Means Many With Advanced Prostate Cancer Are Missing Treatments
TUESDAY, March 21, 2023 (HealthDay News) — An ongoing shortage of a drug for men with advanced prostate cancer is causing some patients to miss months of potentially life-extending treatment. The drug’s maker, Novartis Pharmaceuticals Corp., has said…
Learn MoreDigital Rectal Exam Does Not Detect Early-Stage Prostate Cancer
TUESDAY, March 21, 2023 (HealthDay News) — A digital rectal exam (DRE) conducted in men at age 45 years seems not to be useful for detecting early-stage prostate cancer, according to a study presented at the annual congress of the European Associatio…
Learn MoreLong-Term Study Supports ‘Watch and Wait’ for Most Prostate Cancers
MONDAY, March 13, 2023 (HealthDay News) — A man with prostate cancer who takes the “watch-and-wait” approach has the same long-term survival odds as those who undergo radiation therapy or surgery, according to a new large-scale study.Patients had the…
Learn MoreLow Prostate Cancer-Specific Mortality Seen for Men With Localized Disease
MONDAY, March 13, 2023 (HealthDay News) — For men with localized prostate cancer, prostate cancer-specific mortality is low at 15-year follow-up, regardless of treatment assigned, according to a study published online March 11 in the New England Jour…
Learn More2014 to 2021 Saw Increase in Use of Active Surveillance for Low-Risk Prostate Cancer
WEDNESDAY, March 8, 2023 (HealthDay News) — From 2014 to 2021, the rates of active surveillance for low-risk prostate cancer increased, but considerable practice- and practitioner-level variation is seen in its use, according to a study published onl…
Learn MoreNine Novel Prostate Cancer Variants Identified in Men With African Ancestry
TUESDAY, March 7, 2023 (HealthDay News) — In a study of men of African ancestry, published online March 3 in European Urology, nine novel prostate cancer risk variants have been identified.Fei Chen, Ph.D., from the Keck School of Medicine at the Univ…
Learn MoreMagnitude of Reduction in PSA Level May Indicate Outcomes in Prostate Cancer
MONDAY, March 6, 2023 (HealthDay News) — Greater depth of prostate-specific antigen (PSA) decline is associated with improved clinical outcomes among men treated with enzalutamide for nonmetastatic castration-resistant prostate cancer, according to a…
Learn MoreBreast, Cervical, Prostate Cancer Screening Still Lower Than Before Pandemic
FRIDAY, March 3, 2023 (HealthDay News) — Among age-eligible adults in the United States, the prevalence of past-year screening for breast, cervical, and prostate cancer continued to be lower in 2021 than prepandemic levels, according to a study publi…
Learn MoreCambiar a una dieta de origen vegetal podría mejorar la supervivencia en el cáncer de próstata
JUEVES, 16 de febrero de 2023 (HealthDay News) — Seguir una dieta saludable de origen vegetal tras un diagnóstico de cáncer de próstata podría ayudar a prevenir que la enfermedad progrese o recurra, sugiere un estudio reciente.Los hombres que comían …
Learn More